yclopentolate
yclopentolate Brand names, yclopentolate Analogs
yclopentolate Brand Names Mixture
- No information avaliable
yclopentolate Chemical_Formula
C17H25NO3
yclopentolate RX_link
No information avaliable
yclopentolate fda sheet
yclopentolate msds (material safety sheet)
yclopentolate Synthesis Reference
No information avaliable
yclopentolate Molecular Weight
291.385 g/mol
yclopentolate Melting Point
139 oC (hydrochloride salt)
yclopentolate H2O Solubility
No information avaliable
yclopentolate State
Solid
yclopentolate LogP
3.124
yclopentolate Dosage Forms
Ophthalmic solution (eye drops)
yclopentolate Indication
Used mainly to produce mydriasis and cycloplegia for diagnostic purposes.
yclopentolate Pharmacology
Cyclopentolate is an anti-muscarinic in the same class as atropine and scopolamine. Cyclopentolate blocks the receptors in the muscles of the eye (muscarinic receptors). These receptors are involved controlling the pupil size and the shape of the lens. Cyclopentolate thus induces relaxation of the sphincter of the iris and the ciliary muscles. When applied topically to the eyes, it causes a rapid, intense cycloplegic and mydriatic effect that is maximal in 15 to 60 minutes; recovery usually occurs within 24 hours. The cycloplegic and mydriatic effects are slower in onset and longer in duration in patients who have dark pigmented irises.
yclopentolate Absorption
Absorbed following ophthalmic administration.
yclopentolate side effects and Toxicity
Oral LD50 in the rat is 4000 mg/kg and 960 mg/kg in the mouse. Symptoms of overdose include tachycardia, dizziness, dry mouth, behavioral disturbances, uncoordination and drowsiness.
yclopentolate Patient Information
No information avaliable
yclopentolate Organisms Affected
Humans and other mammals
